SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-100714
Filing Date
2023-04-13
Accepted
2023-04-13 17:20:55
Documents
14
Period of Report
2023-04-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d438476d8k.htm   iXBRL 8-K 35359
2 EX-10.1 d438476dex101.htm EX-10.1 79338
3 EX-99.1 d438476dex991.htm EX-99.1 14207
  Complete submission text file 0001193125-23-100714.txt   279442

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA anik-20230413.xsd EX-101.SCH 2844
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE anik-20230413_lab.xml EX-101.LAB 17235
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE anik-20230413_pre.xml EX-101.PRE 10808
8 EXTRACTED XBRL INSTANCE DOCUMENT d438476d8k_htm.xml XML 3225
Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Filer) CIK: 0000898437 (see all company filings)

IRS No.: 043145961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14027 | Film No.: 23819171
SIC: 3841 Surgical & Medical Instruments & Apparatus